ArticleJournal of thoracic disease2025
Predicting the clinical prognosis of non-small cell lung cancer patients by predicting ALOX5 expression: a radiomics model.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study.Translational lung cancer research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arachidonic acid 5-lipoxygenase (ALOX5) may play an important role in non-small cell lung cancer (NSCLC) progression and treatment and may be a potential prognostic biomarker for NSCLC. This study aimed to predict the clinical prognosis of NSCLC patients by predicting ALOX5 expression using a radiomics model. Methods: Clinical and transcriptomic data of NSCLC patients were obtained from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases and used for survival analysis (Kaplan-Meier survival curves: univariate and multivariate factors, Cox regression analysis, subgroup analysis and interaction test), correlation analysis of tumor clinical characteristics and immune cell abundance, and differential analysis of ferroptosis-related genes to evaluate the prognostic value of ALOX5. Contrast-enhanced computed tomography (CECT) scans of NSCLC patients from The Cancer Imaging Archive (TCIA) database were used to extract radiomics features to establish two radiomics models [logistic regression (LR) and Support Vector Machine (SVM) models]. Receiver operating characteristic (ROC), calibration, and decision curves were used to evaluate the two models, and the radiomics score (RS) of the model with the best prediction performance was selected to establish the Cox model for predicting NSCLC prognosis. A nomogram was used to visualize the prediction model, and its efficacy was evaluated and verified. Results: The prognostic value analysis of ALOX5 showed that high ALOX5 expression was a protective factor for overall survival (OS) of NSCLC patients, and it negatively correlated with histology (P<0.001). Overall, 107 features were obtained from CECT images of NSCLC patients, and 8 optimal features were selected. The LR [area under the curve (AUC) =0.783] and SVM (AUC =0.763) models with good performance and clinical benefit were established using the LR and SVM algorithms, respectively. The RS output by the LR model strongly correlated with ALOX5 expression (P<0.05). Conclusions: The findings suggest that evaluating ALOX5 expression using a radiomics model to predict the clinical prognosis of NSCLC patients could have potential clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.